Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial

Circulation
Christopher B GrangerEric J Topol

Abstract

Although intravenous heparin is commonly used after thrombolytic therapy, few reports have addressed the relationship between the degree of anticoagulation and clinical outcomes. We examined the activated partial thromboplastin time (aPTT) in 29,656 patients in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) trial and analyzed the relationship between the aPTT and both baseline patient characteristics and clinical outcomes. Intravenous heparin was administered as a 5000-U bolus followed by an initial infusion of 1000 U/h, with dose adjustment to achieve a target aPTT of 60 to 85 seconds. aPTTs were collected 6, 12, and 24 hours after thrombolytic administration. Higher aPTT at 24 hours was strongly related to lower patient weight (P < .00001) as well as older age, female sex, and lack of cigarette smoking (all PT< .0001). At 12 hours, the aPTT associated with the lowest 30-day mortality, stroke, and bleeding rates was 50 to 70 seconds. There was an unexpected direct relationship between the aPTT and the risk of subsequent reinfarction. There was a clustering of reinfarction in the first 10 hours after discontinuation of intravenous heparin. Although the relationship between aPTT and cli...Continue Reading

References

Sep 17, 1977·Lancet·E Marciniak, J P Gockerman
May 1, 1978·Thrombosis Research·B GlimeliusM Höök
Jul 16, 1992·The New England Journal of Medicine·P ThérouxJ McCans
May 30, 1991·The New England Journal of Medicine·J Hirsh
Sep 1, 1974·Clinical Pharmacology and Therapeutics·P J PerryJ C King
Mar 1, 1981·Clinical Pharmacology and Therapeutics·R J CipolleE Haus
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Jul 15, 1993·Annals of Internal Medicine·P Brill-EdwardsJ Hirsh

❮ Previous
Next ❯

Citations

Apr 11, 2003·Current Treatment Options in Cardiovascular Medicine·Richard C. Becker
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·B K Metz, E J Topol
Jul 15, 1997·The American Journal of Cardiology·C P JuergensP J Harris
May 18, 1999·International Journal of Cardiology·C VassanelliI Loschiavo
Jun 17, 1998·Journal of the American College of Cardiology·D B BriegerE J Topol
Jan 22, 2003·Internal Medicine Journal·A T ZimmermannJ D Horowitz
Sep 12, 1996·The New England Journal of Medicine·UNKNOWN Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
Mar 6, 1997·The New England Journal of Medicine·A H Schmaier
Oct 27, 1997·The New England Journal of Medicine·UNKNOWN Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
Jan 10, 1998·The New England Journal of Medicine·C Kearon
Feb 21, 1998·The New England Journal of Medicine·S Frei
May 23, 1998·The New England Journal of Medicine·UNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
Jun 1, 1996·Australian and New Zealand Journal of Medicine·D J AmosH D White
Oct 20, 1998·Australian and New Zealand Journal of Medicine·C B Granger
Jun 27, 2000·Australian and New Zealand Journal of Medicine·P A Tideman
Nov 18, 2000·BMJ : British Medical Journal·A Manhapra, S Borzak
Apr 16, 2004·Heart·M A BrouwerF W A Verheugt
Aug 15, 2012·Canadian Journal of Physiology and Pharmacology·Petr Ostadal, Bohuslav Ostadal
Oct 18, 2000·Biochemical and Biophysical Research Communications·N B PestovN N Modyanov
Oct 20, 1998·American Heart Journal·R A HarringtonS D Berkowitz
May 1, 2007·Future Cardiology·Eric R Bates
Mar 22, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Jean-Pierre Bassand
Dec 18, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M FerringB Ricou
Sep 16, 1998·Clinical Therapeutics·C L LackieA Forrest
Mar 11, 2010·Critical Pathways in Cardiology·Amar KrishnaswamyChristopher P Cannon
Nov 21, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J P TsikourisC F Seifert
Aug 8, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Orieji C Illoh, Kachi Illoh
Apr 22, 2009·Expert Review of Cardiovascular Therapy·Ayman A El-Menyar, Jassim Al Suwaidi
Apr 20, 2010·Expert Review of Cardiovascular Therapy·Wiktor KuliczkowskiVictor Serebruany
Nov 4, 2000·Expert Opinion on Investigational Drugs·J Llevadot, R P Guigliano
Nov 4, 2000·Expert Opinion on Investigational Drugs·L Wallentin

❮ Previous
Next ❯